MedPharm is a world-leading CDMO for topical and transdermal products. We are renowned for our expertise in the design and testing of effective, safe and aesthetically elegant dermatological formulations. Our extensive knowledge has evolved from our 20 years of specialised experience with dermal topical and transdermal development.
We are experts in developing a wide range of semi-solid dosage forms including creams, gels, sprays, foams, ointments, lotions, mousses and lacquers. This proficiency extends to developing transdermal patches across a range of designs, from drug in adhesive to multi-layer.
MedPharm is at the cutting edge of developing ex vivo penetration and disease models for topical formulation development. These models are used to optimise formulation design and target engagement against established and customer-specific biochemical pathways.
MedPharm has a large toolbox of performance testing models ranging from simplistic models used to select the optimised thermodynamics and release of actives from the formulations in vitro release testing (IVRT) to skin models of drug permeation and penetration through to complex ex vivo human skin disease models involving local infections and inflammatory responses associated with these infections or pathway-specific stimulation (e.g. psoriasis, atopic dermatitis, acne, etc).
MedPharm’s proven, cost-effective dermal and transdermal solutions ensure that projects are right the first time, allowing our clients to get to market quicker.